News for MacroGenics Stock (MGNX)

MGNX REMINDER: Kessler Topaz Meltzer & Check, LLP Urges MGNX Investors with Losses to Contact the Firm

Accesswire • 08/11/24

MacroGenics Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds MacroGenics, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit

Accesswire • 08/10/24

Investors Can Take The Lead In The MacroGenics Inc Securities Fraud Lawsuit With The Schall Law Firm

Accesswire • 08/10/24

Class Action Announcement for MacroGenics, Inc. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against MacroGenics, Inc. - Contact Kessler Topaz Meltzer & Check, LLP

GlobeNewsWire • 08/09/24

ROSEN, A LEADING NATIONAL FIRM, Encourages MacroGenics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MGNX

GlobeNewsWire • 08/09/24

Important September 24, 2024 Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds MacroGenics, Inc. Investors of Securities Fraud Class Action Lawsuit

Accesswire • 08/09/24

MacroGenics (MGNX) Halts Prostate Cancer Trial After Fatal Adverse Events, Investor Suit - Hagens Berman

Accesswire • 08/09/24

MGNX Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges MGNX Investors with Losses to Contact the Firm

PRNewsWire • 08/09/24

Investors Have Opportunity To Lead MacroGenics Inc Securities Fraud Lawsuit With The Schall Law Firm

Accesswire • 08/09/24

MacroGenics, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before September 24, 2024 to Discuss Your Rights - MGNX

PRNewsWire • 08/08/24

MGNX Investors Can Take The Lead In The MacroGenics Inc Securities Fraud Lawsuit With The Schall Law Firm

Accesswire • 08/08/24

MacroGenics, Inc. Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Against MGNX

GlobeNewsWire • 08/07/24

MacroGenics (MGNX) Class Action Lawsuit Alert: Johnson Fistel Announces Shareholders with Substantial Losses Have the Opportunity to Lead the Action

PRNewsWire • 08/07/24

MGNX INVESTOR DEADLINE: MacroGenics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Accesswire • 08/07/24

Compared to Estimates, MacroGenics (MGNX) Q2 Earnings: A Look at Key Metrics

Zacks Investment Research • 08/07/24

MacroGenics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – MGNX

Accesswire • 08/07/24

MacroGenics (MGNX) Reports Q2 Loss, Lags Revenue Estimates

Zacks Investment Research • 08/06/24

MGNX Investors Have Opportunity To Lead MacroGenics Inc Securities Fraud Lawsuit With The Schall Law Firm

Accesswire • 08/06/24

MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial Results

GlobeNewsWire • 08/06/24

MacroGenics (MGNX) Faces Class Action After Revealing Investigation of Patient Deaths in TAMARACK Study of Vobra Duo – Hagens Berman

Accesswire • 08/06/24

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages MacroGenics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MGNX

GlobeNewsWire • 08/06/24

MGNX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that MacroGenics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewsWire • 08/05/24

MGNX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that MacroGenics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Business Wire • 08/04/24

Class Action Announcement (MGNX): A Securities Fraud Class Action Lawsuit Was Filed Against MacroGenics, Inc.

Accesswire • 08/03/24

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vicor and MacroGenics and Encourages Investors to Contact the Firm

GlobeNewsWire • 08/03/24